These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25159482)

  • 1. Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.
    Joshi N; Biswas J; Nath C; Singh S
    Mol Neurobiol; 2015 Aug; 52(1):330-40. PubMed ID: 25159482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiapoptotic activity of melatonin in neurodegenerative diseases.
    Wang X
    CNS Neurosci Ther; 2009; 15(4):345-57. PubMed ID: 19818070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.
    Pandi-Perumal SR; BaHammam AS; Brown GM; Spence DW; Bharti VK; Kaur C; Hardeland R; Cardinali DP
    Neurotox Res; 2013 Apr; 23(3):267-300. PubMed ID: 22739839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
    Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin oxidative stress and neurodegenerative diseases.
    Srinivasan V
    Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.
    Onaolapo OJ; Onaolapo AY; Olowe OA; Udoh MO; Udoh DO; Nathaniel TI
    Curr Neuropharmacol; 2020; 18(7):563-577. PubMed ID: 31885352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is melatonin ready to be used in preterm infants as a neuroprotectant?
    Biran V; Phan Duy A; Decobert F; Bednarek N; Alberti C; Baud O
    Dev Med Child Neurol; 2014 Aug; 56(8):717-23. PubMed ID: 24575840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of melatonin in the brain of the senescence-accelerated mice-prone 8 (SAMP8) model].
    Gutierrez-Cuesta J; Tajes M; Jimenez A; Camins A; Pallas M
    Rev Neurol; 2011 May; 52(10):618-22. PubMed ID: 21488009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence.
    Tan HY; Ng KY; Koh RY; Chye SM
    Cell Mol Neurobiol; 2020 Jan; 40(1):25-51. PubMed ID: 31435851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Melatonin in Aluminum-Related Neurodegenerative Disorders: a Review.
    Esparza JL; Gómez M; Domingo JL
    Biol Trace Elem Res; 2019 Mar; 188(1):60-67. PubMed ID: 29732485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Melatonin as a drug: present status and perspectives].
    Arushanian ÉB
    Eksp Klin Farmakol; 2014; 77(6):39-44. PubMed ID: 25102735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.
    Ramos E; Egea J; de Los Ríos C; Marco-Contelles J; Romero A
    Future Med Chem; 2017 May; 9(8):765-780. PubMed ID: 28498717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin hormone as a therapeutic weapon against neurodegenerative diseases.
    Asefy Z; Khusro A; Mammadova S; Hoseinnejhad S; Eftekhari A; Alghamdi S; Dablool AS; Almehmadi M; Kazemi E; Sahibzada MUK
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):99-106. PubMed ID: 34933727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant properties of melatonin and its potential action in diseases.
    Karaaslan C; Suzen S
    Curr Top Med Chem; 2015; 15(9):894-903. PubMed ID: 25697560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative damage in the central nervous system: protection by melatonin.
    Reiter RJ
    Prog Neurobiol; 1998 Oct; 56(3):359-84. PubMed ID: 9770244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury.
    Wang X; Figueroa BE; Stavrovskaya IG; Zhang Y; Sirianni AC; Zhu S; Day AL; Kristal BS; Friedlander RM
    Stroke; 2009 May; 40(5):1877-85. PubMed ID: 19299628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs.
    Alamdari AF; Rahnemayan S; Rajabi H; Vahed N; Kashani HRK; Rezabakhsh A; Sanaie S
    Pharmacol Res; 2021 Nov; 173():105839. PubMed ID: 34418564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and the aging brain.
    Bondy SC; Sharman EH
    Neurochem Int; 2007 Mar; 50(4):571-80. PubMed ID: 17276551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.
    Sureda FX; Junyent F; Verdaguer E; Auladell C; Pelegri C; Vilaplana J; Folch J; Canudas AM; Zarate CB; Pallès M; Camins A
    Curr Pharm Des; 2011; 17(3):230-45. PubMed ID: 21348832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.